Dr. Moasser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1825 fourth street
San Francisco, CA 94158Phone+1 415-353-7070Fax+1 415-353-7021- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1991 - 1996
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1988 - 1991
Tufts University School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 2004 - 2025
NY State Medical License 1989 - 2005- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 2006 Feb 01
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 Start of enrollment: 2007 Aug 01
- Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies Start of enrollment: 2012 Mar 27
Publications & Presentations
PubMed
- A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.Ozge Gumusay, Laura A Huppert, Mark Jesus M Magbanua, Michael Assefa, Amy Jo Chien, Michelle E Melisko, Melanie C Majure, Mark Moasser, John Park, Hope S Rugo, Chiara ...> ;Breast Cancer Research and Treatment. 2024 Jan 1
- 13 citationsA reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFcolorectal tumors.Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Bo Pan, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spa...> ;Nature Cancer. 2023 Feb 1
- 2 citationsMolecular Pathways and Mechanisms of HER2 in Cancer Therapy.Kanwal P S Raghav, Mark M Moasser> ;Clinical Cancer Research. 2023 Jul 5
- Join now to see all
Press Mentions
Trial Confirms That Perjeta Extends Survival in Metastatic Breast CancerSeptember 28th, 2014
Solving the Mystery of a Stubborn, and Common, Cancer GeneMarch 5th, 2022
Grant Support
- Understanding Resistance To HER Family Tyrosine Kinase InhibitorsNational Cancer Institute2007–2011
- Adhesion Signaling By A Novel Mitotic Substrate Of SRCNational Cancer Institute2005–2009
- Pilot Studies To Develop Probes For In Vivo Imaging Of P13k/Akt Pathway ActivityNational Cancer Institute2007–2008
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
